Evidence map›Paper›PMID 20433745›Full record

SynthesisRespiratory research2010

Exhaled carbon monoxide in asthmatics: a meta-analysis.

Jingying Zhang, Xin Yao, Rongbin Yu, Jianling Bai, Yun Sun, Mao Huang, Ian M Adcock, Peter J Barnes

Open access · goldAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in Respiratory research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Neutrophils and Asthma.Diagnostics (Basel, Switzerland) · 2022
    Review
  8. Review
  9. Observational
  10. Article
  11. Carbon monoxide in the treatment of sepsis.American journal of physiology. Lung cellular and molecular physiology · 2015
    Review
  12. Article
  13. Article
  14. Asthma across the ages: knowledge gaps in childhood asthma.The Journal of allergy and clinical immunology · 2014
    Review
  15. Review
  16. Therapeutic applications of carbon monoxide.Oxidative medicine and cellular longevity · 2013
    Review
  17. Article
  18. Review
  19. Nicotine Dependence, Its Risk Indicators, and Exhaled Carbon Monoxide Levels among the Smokers in Bengaluru, India.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Jingying ZhangDepartment of Respiratory Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xin Yao
Rongbin Yu
Jianling Bai
Yun Sun
Mao Huang
Ian M Adcock
Peter J Barnes
Jiangsu Province Hospital · CNNanjing Medical University · CNImperial College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe non-invasive assessment of airway inflammation is potentially advantageous in asthma management. Exhaled carbon monoxide (eCO) measurement is cheap and has been proposed to reflect airway inflammation and oxidative stress but current data are conflicting. The purpose of this meta-analysis is to determine whether eCO is elevated in asthmatics, is regulated by steroid treatment and reflects disease severity and control.

methodsA systematic search for English language articles published between 1997 and 2009 was performed using Medline, Embase and Cochrane databases. Observational studies comparing eCO in non-smoking asthmatics and healthy subjects or asthmatics before and after steroid treatment were included. Data were independently extracted by two investigators and analyzed to generate weighted mean differences using either a fixed or random effects meta-analysis depending upon the degree of heterogeneity.

results18 studies were included in the meta-analysis. The eCO level was significantly higher in asthmatics as compared to healthy subjects and in intermittent asthma as compared to persistent asthma. However, eCO could not distinguish between steroid-treated asthmatics and steroid-free patients nor separate controlled and partly-controlled asthma from uncontrolled asthma in cross-sectional studies. In contrast, eCO was significantly reduced following a course of corticosteroid treatment.

conclusionseCO is elevated in asthmatics but levels only partially reflect disease severity and control. eCO might be a potentially useful non-invasive biomarker of airway inflammation and oxidative stress in nonsmoking asthmatics.

Indexed as

ExhalationAdultAnti-Asthmatic AgentsAsthmaBiomarkersBreath TestsCarbon MonoxideChildHumansInflammation MediatorsOxidative StressPredictive Value of TestsSeverity of Illness IndexSteroidsTreatment OutcomeUp-RegulationAnti-Asthmatic AgentsBiomarkersCarbon MonoxideInflammation MediatorsSteroids

Identifiers

PMID20433745
PMCPMC2874770
OpenAlexW1996683196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.